synthetic oligonucleotides
EnPlusOne Biosciences Nabs Exclusive License to RNA Synthesis Technology from Wyss Institute
EnPlusOne Bio has secured a worldwide license to the ezRNA platform developed in the lab of George Church, one of the firm's cofounders.
GenScript, Allozymes Partner on Enzyme Discovery and Development Services
GenScript will provide mutant synthetic DNA libraries and protein expression while Allozymes will offer high-throughput screening services.
Wayfinder Biosciences Raises $3.5M in Seed Funding
The Seattle-based startup said it would use the funds to scale its RNA design platform, with a focus on expanding into therapeutics.
The latest George Church startup says its platform technology can deliver enzymatically synthesized RNA at a commercial scale in the near future.
Enzymatic RNA Synthesis Firm EnPlusOne Biosciences Launches With $12M in Seed Funding
The Harvard spinout, cofounded by George Church, plans to synthesize and supply oligonucleotides greater than 100-nt in length with its ezRNA synthesis platform.